Taurolin, a new chemotherapeutic agent.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004927:Escherichia coli Infections / Q000188:drug therapy; D005243:Feces / Q000382:microbiology; D008297:Male; D051379:Mice; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology; D011512:Proteus Infections / Q000188:drug therapy; D011514:Proteus vulgaris; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa; D012480:Salmonella Infections / Q000188:drug therapy; D012486:Salmonella typhimurium; D013829:Thiadiazines / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D013829:Thiadiazines; D013843:Thiazines